Authors



Sen-Te Wang, MD

Latest:

Impact of COVID-19 Pandemic on Accessibility of Taiwanese Medical Care

The COVID-19 pandemic disrupted access to routine medical care in community populations in Taiwan. The unmet needs should be emphasized as normal life resumes.



Lindsay Jubelt, MD, MS

Latest:

Tacking Upwind: Reducing Spending Among High-risk Commercially Insured Patients

Although commercial accountable care organization populations are healthy on average, some individuals might benefit from programs for high-risk patients to mitigate high levels of health care utilization.


Heidi Anne Duerr, MPH

Latest:

Mental Health Concerns Prevalent in Patients With AD, Poster Says

A new study presented at this year’s American College of Allergy, Asthma and Immunology Annual Scientific Meeting highlights the need for mental health support in patients with atopic dermatitis (AD).



Annie Yu-An Chen, DDS, MS

Latest:

Pediatric Oral Health Services in Medicaid Managed Care and Fee for Service

Rates of preventive oral health services among pediatric medical visits in Florida were similar whether visits were paid via Medicaid comprehensive managed care or fee for service.


Joan F. Brazier, MS

Latest:

How Medicare Advantage Plans Use Data for Supplemental Benefits Decision-Making

This article presents findings from interviews conducted with executives from 29 Medicare Advantage plans regarding plan decision-making processes related to new social risk factor–related benefits.


Andrew Perlman, MPH

Latest:

The Impact of Nurse Practitioner Attribution in Medicare Shared Savings ACOs

Allowing nurse practitioners to serve as attribution-eligible providers for Medicare Shared Savings Program accountable care organizations leads to no change in hierarchical condition category risk scores and modest growth in attributed beneficiaries.


Maddi Hebebrand

Latest:

Dupilumab Treatment for Patients With CSU: Insights From Jason Hawkes, MD, MS

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron Pharmaceuticals) in the management of chronic spontaneous urticaria (CSU), a condition with limited therapeutic options over the past decade.


Isabella Rubin, BA

Latest:

End-of-Life Values and Value-Based Care

An editorial in response to the editor in chief’s December 2021 letter discusses evidence supporting the cost-effectiveness of an innovative advance care planning initiative.


Fawwaz Haq, MD, MBA

Latest:

Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans

This study provides insight on the experiences of patients of a national health plan with 2 structural determinants of health—health care discrimination and health literacy—and how those interact with social determinants of health and patient demographics.


Jeffrey Velotta, MD

Latest:

Examining The Pathophysiology Of Bronchiectasis

Panelists discusses how the "vicious vortex model" explains bronchiectasis pathophysiology, where airway dilatation leads to mucus stagnation, chronic infections, and neutrophilic inflammation, worsening the condition.


Jonathan Davis, MD, MS

Latest:

Reducing Readmissions in the Safety Net Through AI and Automation

Artificial intelligence (AI) and electronic health record–based automation tools helped a safety-net health system meet performance-based readmission metrics, thereby retaining critical funding while improving clinical and equity outcomes.


Chris Ambrose, MD, MBA

Latest:

Clinical and Economic Burden of Uncontrolled Severe Noneosinophilic Asthma

Among patients with severe asthma with low eosinophils untreated with biologics, there is a high burden of disease among those who have suboptimal disease control.


Pradeep Sharma, MS, MBA

Latest:

Social Determinants of Health and Emergency Department Utilization in Alabama Children’s Health Insurance Program

Community social determinants of health such as rurality and low socioeconomic status moderate the association between an individual’s race and emergency care use.


George S. Nasra, MD, MBA

Latest:

Employer-Sponsored Behavioral Health Program Impacts on Care Utilization and Cost

Provision of enhanced access to behavioral health services by a large employer to its employees is associated with reductions in all-cause care utilization and cost.


Olivia S. Jung, PhD

Latest:

Psychological Safety and Use of Incident Reporting Systems

Incident reporting systems, which are often computer based and require no in-person interactions, can enable health care staff who perceive low psychological safety to speak up.



Eva DuGoff, PhD, MPP

Latest:

Quality, Health, and Spending in Medicare Advantage and Traditional Medicare

In a review of literature published since the Affordable Care Act’s passage, more than half of analyses find that Medicare Advantage outperforms traditional Medicare on quality, health, and cost outcomes.


Anil N. Makam, MD, MAS

Latest:

Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury

Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.


John Browne, PhD

Latest:

Is the QALY Fit for Purpose?

The quality-adjusted life-year (QALY) is a popular tool for value assessment but is flawed. This paper highlights potential solutions.


Sehrish Panjwani, PharmD, BSPS, BCGP

Latest:

Appropriate ED Utilization Leading to Better Care Coordination

Addressing avoidable emergency department (ED) utilization takes interventions in partnership with providers.


Andrew Watson, MD, MLitt, FACS

Latest:

Contributor: Sustaining the “New Normal”—The Future Is Still Bright for Telehealth in the Wake of COVID-19

Consumers want telehealth and telehealth can help achieve organizational goals of avoiding unplanned care, closing care gaps, and achieving care targets.


Jingyi Zheng, PhD

Latest:

Use of Second-Generation Antidiabetic Medication Among a Nationally Representative Sample

Among individuals with a diagnosis of type 2 diabetes across the United States, income level, hemoglobin A1c, and comorbidity burden were the primary patient-level drivers of the use of newer antidiabetic agents.


Hope Rugo, MD

Latest:

ASCO 2024 Review and Needed Future Research in CDK4/6 inhibitors Early Breast Cancer

A panel of experts review ASCO 2024 and the need for future research in CDK4/6 inhibitors.


Brent Stice, MBA

Latest:

Value-Based Care Through Postacute Home Health Under CMS PACT Regulations

Among a patient population defined by CMS postacute care transfer regulations, home health vs no postacute care was associated with reduced 30-day readmissions and costs.


Philip S. Brenner, PhD

Latest:

Patient Perceptions of In-home Urgent Care via Mobile Integrated Health

Comparing patients’ experiences with in-home urgent care from community paramedics vs urgent care provided in emergency departments, we found higher satisfaction among patients receiving in-home treatment.


Stella E. Sechopoulos, BA

Latest:

Leveraging Patient Activation to Improve Kidney Health in High-Risk Patients

Frequency of patient-provider conversations and patient activation are the 2 most significant predictors of a high-risk patient’s behaviors to prevent kidney disease.


AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo